CVS Health exceeded Wall Street expectations for the second quarter, raising its full-year forecast. The company filled more prescriptions and saw revenue growth in all three business segments. Adjusted earnings were $1.81 per share, beating analyst predictions. Net income dropped 42% due to litigation charges.

CVS Health anticipates adjusted 2025 earnings to range between $6.30 and $6.40 this year. Revenue grew 8% to $98.9 billion, with a 4% increase in prescriptions filled. Net income decreased by 42% to $1.02 billion. Company shares rose nearly 5% to $65.32, reflecting a 39% increase this year.

Read more at Yahoo Finance: CVS Health hikes 2025 forecast again, boosted by insurance, pharmacy businesses